Copyright Reports & Markets. All rights reserved.

Global Transmucosal Drug Delivery Systems Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral Drug Delivery
      • 1.4.3 Nasal Drug Delivery
      • 1.4.4 Rectal Drug Delivery
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Transmucosal Drug Delivery Systems Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Transmucosal Drug Delivery Systems Market Size
    • 2.2 Transmucosal Drug Delivery Systems Growth Trends by Regions
      • 2.2.1 Transmucosal Drug Delivery Systems Market Size by Regions (2019-2025)
      • 2.2.2 Transmucosal Drug Delivery Systems Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Transmucosal Drug Delivery Systems Market Size by by Players
      • 3.1.1 Global Transmucosal Drug Delivery Systems Revenue by by Players (2014-2019)
      • 3.1.2 Global Transmucosal Drug Delivery Systems Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Transmucosal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
    • 3.2 Transmucosal Drug Delivery Systems Key Players Head office and Area Served
    • 3.3 Key Players Transmucosal Drug Delivery Systems Product/Solution/Service
    • 3.4 Date of Enter into Transmucosal Drug Delivery Systems Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Transmucosal Drug Delivery Systems Market Size by Type (2014-2019)
    • 4.2 Global Transmucosal Drug Delivery Systems Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Transmucosal Drug Delivery Systems Market Size (2014-2019)
    • 5.2 Transmucosal Drug Delivery Systems Key Players in North America
    • 5.3 North America Transmucosal Drug Delivery Systems Market Size by Type
    • 5.4 North America Transmucosal Drug Delivery Systems Market Size by Application

    6 Europe

    • 6.1 Europe Transmucosal Drug Delivery Systems Market Size (2014-2019)
    • 6.2 Transmucosal Drug Delivery Systems Key Players in Europe
    • 6.3 Europe Transmucosal Drug Delivery Systems Market Size by Type
    • 6.4 Europe Transmucosal Drug Delivery Systems Market Size by Application

    7 China

    • 7.1 China Transmucosal Drug Delivery Systems Market Size (2014-2019)
    • 7.2 Transmucosal Drug Delivery Systems Key Players in China
    • 7.3 China Transmucosal Drug Delivery Systems Market Size by Type
    • 7.4 China Transmucosal Drug Delivery Systems Market Size by Application

    8 Japan

    • 8.1 Japan Transmucosal Drug Delivery Systems Market Size (2014-2019)
    • 8.2 Transmucosal Drug Delivery Systems Key Players in Japan
    • 8.3 Japan Transmucosal Drug Delivery Systems Market Size by Type
    • 8.4 Japan Transmucosal Drug Delivery Systems Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Transmucosal Drug Delivery Systems Market Size (2014-2019)
    • 9.2 Transmucosal Drug Delivery Systems Key Players in Southeast Asia
    • 9.3 Southeast Asia Transmucosal Drug Delivery Systems Market Size by Type
    • 9.4 Southeast Asia Transmucosal Drug Delivery Systems Market Size by Application

    10 India

    • 10.1 India Transmucosal Drug Delivery Systems Market Size (2014-2019)
    • 10.2 Transmucosal Drug Delivery Systems Key Players in India
    • 10.3 India Transmucosal Drug Delivery Systems Market Size by Type
    • 10.4 India Transmucosal Drug Delivery Systems Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Transmucosal Drug Delivery Systems Market Size (2014-2019)
    • 11.2 Transmucosal Drug Delivery Systems Key Players in Central & South America
    • 11.3 Central & South America Transmucosal Drug Delivery Systems Market Size by Type
    • 11.4 Central & South America Transmucosal Drug Delivery Systems Market Size by Application

    12 International Players Profiles

    • 12.1 3M
      • 12.1.1 3M Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Transmucosal Drug Delivery Systems Introduction
      • 12.1.4 3M Revenue in Transmucosal Drug Delivery Systems Business (2014-2019))
      • 12.1.5 3M Recent Development
    • 12.2 Antares Pharma
      • 12.2.1 Antares Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Transmucosal Drug Delivery Systems Introduction
      • 12.2.4 Antares Pharma Revenue in Transmucosal Drug Delivery Systems Business (2014-2019)
      • 12.2.5 Antares Pharma Recent Development
    • 12.3 Aveva Drug Delivery Systems
      • 12.3.1 Aveva Drug Delivery Systems Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Transmucosal Drug Delivery Systems Introduction
      • 12.3.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Systems Business (2014-2019)
      • 12.3.5 Aveva Drug Delivery Systems Recent Development
    • 12.4 Corium International
      • 12.4.1 Corium International Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Transmucosal Drug Delivery Systems Introduction
      • 12.4.4 Corium International Revenue in Transmucosal Drug Delivery Systems Business (2014-2019)
      • 12.4.5 Corium International Recent Development
    • 12.5 Acrux Limited
      • 12.5.1 Acrux Limited Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Transmucosal Drug Delivery Systems Introduction
      • 12.5.4 Acrux Limited Revenue in Transmucosal Drug Delivery Systems Business (2014-2019)
      • 12.5.5 Acrux Limited Recent Development
    • 12.6 ALZA Corporation
      • 12.6.1 ALZA Corporation Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Transmucosal Drug Delivery Systems Introduction
      • 12.6.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Systems Business (2014-2019)
      • 12.6.5 ALZA Corporation Recent Development
    • 12.7 DURECT Corporation
      • 12.7.1 DURECT Corporation Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Transmucosal Drug Delivery Systems Introduction
      • 12.7.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Systems Business (2014-2019)
      • 12.7.5 DURECT Corporation Recent Development
    • 12.8 Generex Biotechnology
      • 12.8.1 Generex Biotechnology Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Transmucosal Drug Delivery Systems Introduction
      • 12.8.4 Generex Biotechnology Revenue in Transmucosal Drug Delivery Systems Business (2014-2019)
      • 12.8.5 Generex Biotechnology Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Transmucosal Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transmucosal Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      3M
      Antares Pharma
      Aveva Drug Delivery Systems
      Corium International
      Acrux Limited
      ALZA Corporation
      DURECT Corporation
      Generex Biotechnology

      Market segment by Type, the product can be split into
      Oral Drug Delivery
      Nasal Drug Delivery
      Rectal Drug Delivery
      Other

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Transmucosal Drug Delivery Systems status, future forecast, growth opportunity, key market and key players.
      To present the Transmucosal Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Transmucosal Drug Delivery Systems are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now